The Louisiana State University Health Sciences Center in New Orleans Centers of Excellence were established by the Louisiana State University Board of Regents.. The Centers of Excellence consist of the following:

Alcohol and Drug Abuse Center, 1991
This Center enhances the research capabilities of scientists, stimulates collaborative research efforts and strengthens educational activities in the biomedical aspects of alcohol and substance abuse throughout the Health Sciences Center.

Cardiovascular Center, 1991
The goal of the Cardiovascular Center is to improve the understanding and management of cardiovascular diseases by developing a multidisciplinary approach that integrates close, collaborative efforts among programs in basic and clinical research, clinical management, prevention, and epidemiologic and genetic studies.

Center for Molecular and Human Genetics, 1991
Augment the contribution of genetics to clinical medicine and biotechnology, clinical genetic services, training and education in genetics augment the contribution of genetics to clinical medicine and biotechnology, and more

Center for Oral and Craniofacial Biology, 1994
The Center of Excellence in Oral and Craniofacial Biology is a multidisciplinary center to provide, in an efficient cost effective manner, the resources to promote and facilitate dental research, intellectual stimulation, and a network for research opportunities and collaboration.

Epilepsy Center, 2002
The Epilepsy Center of Excellence is dedicated to providing breakthrough multidisciplinary epilepsy research in pharmacology, neuroelectrophysiology, neuroimaging, neurosurgery, biomedical engineering and public health, which leads to newer treatments and potential cures such as epilepsy surgery.

Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center, 1996
A center dedicated to patient education, advanced patient care, and to finding the answers that will eventually cure asthma.

Eye Center, 1999
The Eye Center faculty is known for pioneering work in laser vision correction, cataract and other refractive surgeries, viral and bacterial eye disease, corneal transplantation and cornea preservation, confocal microscopy, glaucoma, wound healing, drug delivery, contact lenses, diabetic eye disease, macular degeneration, retinitis pigmentosa and other retinal diseases and degeneration.

The Gene Therapy Program, 2000
The Gene Therapy Program is focused on the development of novel treatments for human disease, including cancer, infectious diseases such as HIV/AIDS and TB, cystic fibrosis, and neurodegenerative disorders. The major research strategy of the Program is gene delivery for disease therapy or prevention, either through the replacement of “missing” genes, or via modulation of immune function through delivery of vaccine antigens or immune response modifiers.  The Program is an integral component of the Louisiana Gene Therapy Research Consortium and interacts extensively with partner Programs at LSU-Shreveport and Tulane.
 
Neurosciences Center, 1988
The mission of the Center is to contribute to the creation of an environment of high standards, where investigations on the nervous system and the diseases that affect it are conducted. To this end, the identification and recruitment of outstanding faculty to build a critical mass of expertise is already a tangible asset.

The Research Institute for Children, 2005
The Research Institute for Children performs research that will improve the quality of children's health, provides an opportunity for young scientists and physicians to train in an outstanding research environment, and educates children in the life sciences and scientific method.

Stanley S. Scott Cancer Center, 1991
The mission of the Stanley S. Scott Cancer Center is to decrease cancer incidence and mortality in the State of Louisiana. Particular emphasis at the Cancer Center is placed on those citizens with the greatest need.